linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
CRISIL Ltd.
 
Source DateBoard Meeting DateDetails
01 Apr 202616 Apr 2026 Interim Dividend & Quarterly Results
05 Jan 202612 Feb 2026 Audited Results & Final Dividend
01 Oct 202517 Oct 2025 Quarterly Results & Interim Dividend
01 Jul 202521 Jul 2025 Interim Dividend & Quarterly Results
01 Apr 202530 Apr 2025 Quarterly Results & First Interim Dividend
02 Jan 202510 Feb 2025 Final Dividend & Audited Results
01 Oct 202416 Oct 2024 Interim Dividend & Quarterly Results
01 Jul 202416 Jul 2024 Quarterly Results & Second Interim Dividend The Meeting of the Board of Directors of the Company will be held on Monday and Tuesday, July 15, 2024 and July 16, 2024 to consider and approve the unaudited consolidated and standalone financial results for the second quarter ended June 30, 2024 and to consider the payment of second Interim Dividend for the financial year ending December 31, 2024. The unaudited financial results for the quarter ended June 30, 2024, and the proposal for dividend will be presented to the Board of Directors on July 16, 2024, for their approval
08 Apr 202416 Apr 2024 Interim Dividend & Quarterly Results
07 Feb 202416 Feb 2024 Audited Results (Revised) & Final Dividend
31 Oct 202307 Nov 2023 Third Interim Dividend & Quarterly Results
10 Jul 202317 Jul 2023 Quarterly Results & Interim Dividend
10 Apr 202318 Apr 2023 First Interim Dividend & Quarterly Results
09 Feb 202317 Feb 2023 Final Dividend & Audited Results
14 Oct 202221 Oct 2022 Third Interim Dividend & Quarterly Results
13 Jul 202221 Jul 2022 Second Interim Dividend & Quarterly Results
13 Apr 202221 Apr 2022 Quarterly Results & First Interim Dividend
08 Feb 202215 Feb 2022 Dividend & Audited Results
02 Nov 202110 Nov 2021 Quarterly Results & Interim Dividend
12 Jul 202120 Jul 2021 Second Interim Dividend & Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.